GlassScriptPhysician profile
John S Stewart
NPI 1447220926
$2,169.19
in general payments reported to CMS, 2019-2025
11 companies · $443 in 2025
The $443 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $360 · 2021: $686 · 2022: $118 · 2023: $326 · 2024: $60.29 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $829.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,147.89 | 2019-2025 | Xpress Loprofile, Scopis Ent, Focess |
| Medtronic, INC. | $216.87 | 2021-2025 | Alar, Propel |
| Optinose US, INC. | $179.91 | 2020-2022 | |
| Genzyme Corporation | $155.13 | 2021-2023 | |
| Intersect Ent, INC. | $138.81 | 2019-2020 | |
| Glaxosmithkline, LLC. | $90.20 | 2021-2024 | Nucala |
| Regeneron Healthcare Solutions, INC. | $74.50 | 2020-2022 | |
| Novo Nordisk INC | $71.73 | 2022-2024 | Rybelsus, Ozempic |
| Kaleo, INC. | $33.34 | 2021 | |
| Neurent Medical Limited | $30.75 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Aerin Medical INC. | $30.06 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.